Xun Dong
Direktor/Vorstandsmitglied bei SINOMAB BIOSCIENCE LIMITED
Profil
Xun Dong is currently the Director at Yunnan Institute of Materia Medica and a Non-Executive Director at Sinomab Bioscience Ltd.
He previously worked as the Vice President-Sales at Yunnan Baiyao Group Co., Ltd.
Mr. Dong received his graduate degree from the University of Warwick in 2010 and his undergraduate degree from Southampton Business School in 2009.
Aktive Positionen von Xun Dong
| Unternehmen | Position | Beginn |
|---|---|---|
| SINOMAB BIOSCIENCE LIMITED | Direktor/Vorstandsmitglied | 23.12.2019 |
Yunnan Institute of Materia Medica
 Yunnan Institute of Materia Medica Pharmaceuticals: MajorHealth Technology Part of Yunnan Baiyao Group Co., Ltd., Yunnan Institute of Materia Medica is a Chinese pharmaceutical company that manufactures and distributes drugs. The company is based in Kunming, China. Yunnan Institute of Materia Medica was acquired by Yunnan Baiyao Group Co., Ltd. from Yunnan Baiyao Holdings Co., Ltd. on November 26, 2012 for $16.13 million. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Xun Dong
| Unternehmen | Position | Ende |
|---|---|---|
| YUNNAN BAIYAO GROUP CO.,LTD | Vertrieb & Marketing | - |
Ausbildung von Xun Dong
| Southampton Business School | Undergraduate Degree |
| University of Warwick | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SINOMAB BIOSCIENCE LIMITED | Health Technology |
| YUNNAN BAIYAO GROUP CO.,LTD | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Yunnan Institute of Materia Medica
Yunnan Institute of Materia Medica Pharmaceuticals: MajorHealth Technology Part of Yunnan Baiyao Group Co., Ltd., Yunnan Institute of Materia Medica is a Chinese pharmaceutical company that manufactures and distributes drugs. The company is based in Kunming, China. Yunnan Institute of Materia Medica was acquired by Yunnan Baiyao Group Co., Ltd. from Yunnan Baiyao Holdings Co., Ltd. on November 26, 2012 for $16.13 million. | Health Technology |
